NEXON Co., Ltd. has authorized the 29th round of stock option grants, formalizing a compensation package for its Board of Directors. This issuance, approved by the Board of Directors on March 25, 2026, follows the authorization granted during the 19th Annual General Meeting of Shareholders. The primary objective of this initiative is to provide equity-based remuneration to leadership, specifically targeting one member of the Audit and Supervisory Committee, who is an external director.
The grant consists of 4,180 stock acquisition rights, each convertible into one share of common stock, totaling 4,180 shares. These options are issued without requiring cash payment from the recipient. The exercise period spans ten years, commencing on the grant date of April 10, 2026. Eligibility is strictly tied to the recipient’s status as a director, with limited exceptions for former directors in cases of retirement, resignation, or disability, provided such conditions are approved by the Board.
The terms include standard protective provisions for corporate restructuring, such as mergers, demergers, or share exchanges, which allow for the adjustment of share counts or the acquisition of options by the company under specific circumstances. Furthermore, the transfer of these options is restricted and requires prior approval from the Board of Directors. Upon exercise, the increase in paid-in capital and capital reserves will be calculated in accordance with the Company Accounting Ordinance, with the capital increase set at half of the maximum allowable limit. This issuance reflects the company’s ongoing strategy to align director incentives with long-term corporate performance through equity participation.
